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Bronchoalveolar lavage (BAL) was used to sample retention of particles within the alveolar macrophage













) particles in human subjects. Particles were cleared from the lavagable AM com-
partment in a biphasic pattern, with a rapid-phase clearance half-time of 0.5 d and long-term clearance
half-time of 110 d, comparable to retention kinetics determined by more traditional methods. The intracel-
lular distribution of particles within lavaged AMs was similar in bronchial and alveolar BAL fractions.
AMs with high intracellular particle burdens disappeared from the lavagable phagocytic AM population
disproportionately more rapidly (shorter clearance half-time) than did AMs with lower particle burdens,
consistent with the occurrence of a particle redistribution phenomenon as previously described in similar
studies in rats. The rates of AM disappearance from the various particle burden categories was generally
slightly slower in bronchial fractions than in alveolar fractions. The instillation of particles induced a tran-
sient acute inflammatory response at 24 h postinstillation (PI), characterized by increased numbers of neu-
trophils and alveolar macrophages in BAL fluids. This response was subclinical and was resolved within
4 d PI. 
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Knowledge about the role of alveolar macrophages (AMs)
in the long-term retention and clearance of particles de-
posited in the alveolar region of the lung has been derived
predominantly from animal studies. These studies indicate
that AMs rapidly phagocytize particles deposited on the
alveolar surface (1–3). Although some particles may be
transported to regional lymph nodes (4, 5) or become se-
questered in the pulmonary interstitium or epithelium (es-
pecially at high particulate lung burdens), the vast major-
ity are thought to eventually leave the lung as intracellular
particles within AMs, predominantly by the tracheobron-
chial route (6, 7). Thus, particle clearance is intimately
linked to egress of AMs from the lung. Such a scenario is
presumed also to occur in clearance of particles from the
human lung. Animal studies (2, 7, 8) indicate that a pro-
portion of deposited particles remains sequestered in AMs
for extended periods, possibly as a result of “redistribu-
tion” of particles among AMs. This might occur as the re-
sult of exocytosis of particles or release of particles from
lysed senescent AMs and subsequent phagocytosis by new
macrophages. Phagocytized particles may, thus, remain in
the lung via passage from one macrophage to another in-
stead of being cleared from the lung. In addition to physi-
cal transport out of the lung, some portion of a lung parti-
cle burden may be cleared by slow dissolution of particles
within alveolar macrophages (9). The kinetics of particle
clearance from the lungs of different species vary tremen-
dously (10), with humans being the slowest and the rat be-
ing the most rapid in clearing a particle burden. The causes
for this disparity between species are not known and may
include differences in anatomy or fundamental clearance
mechanisms.
Studies in human subjects have examined particle re-
tention and clearance by monitoring radioactivity emitted
from radiolabeled particles deposited in the lung (11–13).
Many investigators have used inhaled particles with short-
lived radiolabels to examine short-term clearance (trache-











 Dr. John C. Lay, UNC, Center for Environ-





 alveolar macrophage, AM; analysis of covariance, AN-
COVA; analysis of variance, ANOVA; bronchoalveolar lavage, BAL;




































AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY VOL. 18 1998
 
during the first 24 to 48 h following deposition (14, 15). A
few studies have used longer lived radiolabels to study
long-term kinetics of particle retention and clearance (11,
13, 16). One study compared long-term pulmonary clear-
ance of inhaled cobalt oxide in multiple species and found
marked differences in particle retention between species
over the 180 d following particle deposition (10). Pulmo-
nary particle retention was definitively greater in humans
and baboons than in the other species studied, clearly dem-
onstrating the limitations of extrapolating animal-derived
clearance data to humans. None of these studies have di-
rectly examined the role of AMs in the retention or removal
of particles deposited in the alveolar region of the human
lung. 
The current study departs from more traditional meth-
ods and directly examines retention and distribution of
particles within AMs lavaged from the lungs of human
subjects following intrapulmonary instillation of particles.
This approach, similar to that employed in previous ani-
mal studies (8), provides a means for evaluating possible
particle redistribution within the human AM compart-
ment. Our objectives were to quantify and compare the re-
tention and intracellular distributions of insoluble parti-
cles within lavagable alveolar and airway macrophages as
a function of time following instillation. By measuring rel-
ative rates of clearance of AMs having different intracellu-
lar particle burdens, we hoped to demonstrate whether
there was a “redistribution” of particles between AMs in
the human lung, similar to that seen in rats. In addition, af-
ter making certain assumptions, we hoped to estimate the
overall particle retention and clearance kinetics for parti-






Thirty healthy, nonsmoking volunteers (24 male, 6 fe-




 4.3 yr) par-
ticipated in the study. Potential subjects were excluded
from participation if they had a history of smoking,
asthma, allergy, cardiac disease, chronic respiratory dis-
ease, or recent acute respiratory illness. All potential sub-
jects underwent screening procedures, including comple-
tion of the Minnesota Multiphasic Personality Inventory
and medical history form, physical examination, chest ra-
diographs, and routine hematological and serum chemistry
tests. Accepted subjects were informed of the purposes,
experimental protocol, and procedures of the experi-
ments, as well as potential risk from participation, and
each subject signed a statement of informed consent. This
study was approved by the Committee on the Protection
of the Rights of Human Subjects of the University of




Subjects were each assigned to one of five groups of six
subjects each. Each subject underwent two bronchoscopy









) microspheres suspended in nonpyro-
genic, sterile physiologic saline solution (SPSS) (Baxter
Healthcare Products, Deerfield, IL) were instilled into an
identified subsegment of the lingula that could readily be
wedged by advancing the bronchoscope. As a control,
SPSS (without particles) was instilled into a segment (me-
dial or lateral) of the right middle lobe. Subsequently, dur-
ing the second bronchoscopy procedure, particles and cells
were recovered by bronchoalveolar lavage (BAL) at a
specified time (1, 2, 4, 28, or 91 d) postinstillation (PI). To-
tal and differential cell counts, total recovered particles,
and particles per cell were tabulated for the bronchial and
alveolar wash fractions.
Iron oxide was chosen as the test particle for this study
because of its safety, and because it is inert and relatively
insoluble in aqueous suspension at neutral pH. It is re-
ported to be nontoxic, nonfibrogenic, and noncarcinogenic
(17), and has been used previously in humans for inhala-












 particles (nonradioactive) were generated









 (23) using a spinning disk aerosol generator
(24), but without radioactive label. The count median di-




m, with a geo-






) of 1.3. The particles were
collected in SPSS in an impinger, concentrated by centrifu-
gation, and then washed twice in SPSS. Initial particle




C for 30 min.





C for 3.5 h, which also ensured the destruction of any
endotoxin activity that might be present in the particle sus-
pension. Batches of all the particle suspensions were
tested for endotoxin activity using a gelation-capillary
method (Endotect; ICN Biomedical, Costa Mesa, CA) or
using a semiquantitative method (performed by the Uni-
versity of North Carolina Tissue Culture Facility), both of




 amebocyte lysate (LAL)
assay. The capillary LAL method detects endotoxin con-
centrations as low as 0.06 to 0.10 ng/ml and provides only a
positive or negative indication of the presence of endot-
oxin. The semiquantitative LAL method is equally as sen-
sitive, and provides an indication of the actual concentra-
tion of endotoxin present. All particle suspensions tested
by the capillary method were negative. Particle suspen-








 0.1 ng/ml). 
Just before instillation, concentrated particles were sus-
pended in 2 to 3 ml of SPSS and placed in an ultrasonic
bath for 30 min to disperse clumps of particles. Particles
were examined and counted in a hemacytometer to assure









 particles were suspended in 10 ml of
SPSS and transferred to a sterile syringe for instillation.
 
Particle Instillation and Bronchoalveolar Lavage
 
Bronchoscopy and BAL were performed as previously de-
scribed (25). Before bronchoscopy, all subjects were pre-
medicated intravenously with 0.6 mg of atropine. The pos-
terior pharynx was anesthetized by gargling with a saline
solution containing 4% lidocaine, and the nasal passage
was anesthetized with a lubricating jelly containing 2%
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lidocaine. The larynx, trachea, and bronchi were anesthe-
tized with topical 2% lidocaine instilled through a fiberop-
tic bronchoscope (BF type 1T20D; Olympus, Lake Suc-
cess, NY) to control coughing. The total dose of instilled
lidocaine was limited to no more than 300 mg.
To instill the particles into the distal airways and alve-
oli, the bronchoscope was passed to a wedgeable subseg-
mental bronchus in the lingula, but was not wedged. A Te-
flon catheter was passed through the biopsy channel and
then extended 4 to 5 cm beyond the tip of the broncho-
scope into the selected subsegmental bronchus. Subjects
were instructed to take deep, slow, and regular breaths.

















spheres was slowly instilled through the catheter coinci-
dent with inspirations to maximize placement of particles
in the alveolar region. This was followed by an additional
10 ml of SPSS from a different syringe (for a total of 20
ml), with the intent of washing particles remaining in air-
ways into the alveoli. As a control, 20 ml of SPSS (without
particles) was similarly instilled into the medial segment of
the right middle lung lobe. To assess the number of parti-
cles that were lost to the syringe and catheter, simulated




 by injecting particle
suspensions through the catheter into a glass vial and count-
ing the particles deposited in the vial. On the basis of these





were lost to the syringe and catheter, so the actual number


























Segmental BAL was performed at a specific time inter-









previously instilled and in the control segment in the right
middle lobe. The lavage of each segment comprised six
washes using a total of 270 ml of SPSS per segment. The
first washing was done with only 20 ml of SPSS, and was
considered to be enriched with materials from the periph-
eral airways (26). BAL fluid from the first wash was kept
separate from five subsequent washings of 50 ml each.
Similarly, the control subsegment was lavaged as de-
scribed. BAL fluid and cells from each individual washing
were collected in separate capped tubes and kept on ice




BAL fluids from the particle-instilled segment (lingula)
and control segment (right middle lobe) were processed
separately, but in identical fashion, as described subse-









min. Cells from the bronchial fraction were kept separate,
whereas cells from the five 50-ml washes (alveolar frac-
tion) were pooled, washed twice with tissue culture me-
dium (RPMI 1640; Sigma Chemical, St. Louis, MO), and
used immediately for total and differential cell counts. To-
tal cell counts were obtained by light microscopy, using a
hemacytometer. Differential cell counts were obtained us-
ing slides prepared in a cytocentrifuge (Cytospin 3; Shan-
don, Pittsburgh, PA) at 500 rpm for 3 min. Slides were
stained with a modified Wright’s stain (Leukostat stain;
Fisher Scientific, Fairlawn, NJ) and at least 300 cells were
counted and evaluated.
 
Analysis of Particle Retention
 
We made the following assumptions regarding the recov-
ery of particles by bronchoalveolar lavage in order to ana-
lyze and interpret the data we collected:
1. The vast majority of particles retained within the lung
are located within alveolar macrophages located within
lavagable airspaces.
2. Translocation of particles from the airspaces into the
pulmonary interstitium is minimal during the 91-d
course of the study.
3. Dissolution of particles is negligible during the 91-d
course of the study. 
4. The number of particles recovered by BAL is propor-
tional to the number of particles present within the
bronchial and alveolar airspaces accessible to lavage.
5. The efficiency of BAL in recovering particles is similar
from one time point to another following particle instil-
lation. 
Counts of particles and intracellular particles per cell





mersion objective lens. One thousand AMs were counted








 particles contained within the
margins of each cell was tabulated. Particles located within
the margins of the cell were assumed to be intracellular
particles and all other particles were considered extracel-
lular. Only intact cells with minimal degenerative cytologi-
cal changes were included in the count. The number of ex-
tracellular particles encountered (per 1,000 macrophages
counted) also was tabulated, as was the number of parti-
cles associated with degenerated cells and particles con-
tained within neutrophils. The total number of particles
recovered by BAL was then calculated using the total
number of intracellular and extracellular particles counted
and the total cell counts. Data from the six subjects at each
time interval were averaged to provide a mean number of
recovered particles for each time point (1, 2, 4, 28, and 91 d
PI). Because we did not attempt lavage to recover parti-
cles immediately following instillation, a value for the
number of particles that might have been recovered by




 0 was estimated by extrapolation, using a sin-
gle exponential decay function fit to data from Days 1 and
2 PI.
By a least-squares method, a double-exponential decay
function (Equation 1) was fit to the data (total particles re-
covered versus time), using computer software (Delta-








) for each of the two components of the
curve was calculated (equation 2) as a function of the ex-








Analysis of Intracellular Particle Distribution
 
The number of AMs containing various particle burdens





20 particles) was determined and expressed as a
percentage of the number of AMs that had phagocytized
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at least one particle (particle-laden AMs), rather than the
total number of AMs recovered (total AMs). (This was
necessary to allow comparisons of the particle distribu-
tions in the alveolar fraction with those in the bronchial
fraction.) A single exponential decay function (Equation
3) was fit by the least-squares method to the mean per-
centage of AMs with a given particle burden to describe
the loss of AMs from the various categories between Days 4




The “one particle per cell” category was a special case that
required a positive exponential function (Equation 4) to
describe the change in percentage of AMs in this category




The half-times or doubling times were calculated as de-
scribed previously (Equation 2).









) derived from Equations 3 or 4
were tabulated by particle burden category and the trend
toward increasing or decreasing rate across the various









 standard error. Dif-
ferences between particle-instilled versus control segments
and for bronchial versus alveolar fractions for various pa-




 test for paired
samples (27). Differences in various parameters (total parti-
cles recovered, particles per phagocytic cell, etc.) at differ-
ent times PI were evaluated using analysis of variance
(ANOVA) and post hoc hypothesis testing for differences
between groups using the pairwise Tukey’s honestly signifi-
cant difference (HSD) test. Pearson’s correlation coefficient
was calculated to determine the significance of trends in
clearance rate constants across particle burden categories,
and analysis of covariance (ANCOVA) was used to com-
pare the trends between bronchial and alveolar fractions.
The rate constants were first transformed to their natural




 value of 0.05 was




Retention of Particles 
 
Retention kinetics of particles recovered by BAL were as-
sumed to be representative of the total burden of particles
within the alveolar spaces (2). On average, no more than
10% of the particles instilled could be recovered by BAL
(combined bronchial and alveolar) at any time PI. The
mean number of particles recovered at 91 d PI was only
32% of that recovered at 1 d PI; however, this difference









to large variances in particle recovery from individuals
within each group. A retention curve fit to the mean val-
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A rapid decrease in lavagable particles occurred during








 0.5 d) and was followed by a much











1.67 107×( ) e 0.0063t–( ) 2.07 107×( ) e 1.41t–( )+
=
Figure 1. Mean number of particles recovered by BAL at various
times PI: A double-exponential decay function fit to the data
shows a very rapid clearance (t1/2 5 0.5 d) during the first 2 d PI,
followed by a prolonged slow clearance phase (t1/2 5 110.1 d).
The fitted equation is as follows: Number of particles 5 (1.671 3
107) (e20.006297t) 1 (2.068 3 107) (e21.4066t). Bars represent stan-
dard error.
Figure 2.  The proportion of free particles in the bronchial frac-
tion (as the percentage of the total counted) tended to be greater
in the early time points (1 to 4 d PI) as compared with the alveo-
lar fraction and the bronchial fraction at 28 or 91 d PI. The per-
centage of free particles in the alveolar fraction was significantly
elevated only at 1 d PI. Bars represent standard error. *Bronchial
fraction statistically different from alveolar fraction (, 0.05,
paired t test). †Bronchial fraction statistically different from bron-
chial fraction at 28 and 91 d PI. ‡Alveolar fraction statistically dif-
ferent from alveolar fraction at 4, 28, and 91 d PI.
 
 








The percentage of particles that were extracellular and not
obviously associated with a cell disrupted during centrifu-
gation was higher in the bronchial fraction and in the early
time points, 1 to 4 d PI (Figure 2) relative to the alveolar
fraction and also to the bronchial fraction at 28 and 91 d
PI. The percentage of free particles in the alveolar BAL






< 0.05) relative to 4,
28, and 91 d PI.
Intracellular Distribution of Particles 
The mean percentage of the total AMs, which had phago-
cytized one or more particles (particle-laden AMs), ap-
peared to increase slightly between 1 and 91 d PI in both
bronchial and alveolar fractions (Figure 3). These appar-
ent increases were not statistically significant. The mean
percentage of particle-laden AMs appeared to be slightly
higher in the bronchial fraction and was significantly
higher than that of the alveolar fraction at 91 d PI (paired
t test, P 5 0.04). There was an apparent decrease of 34.6%
in the total number of particle-laden AMs between 1 and
91 d PI (Figure 3); however, this change was not statisti-
cally significant owing to large variances within groups. 
Alveolar fraction. Particles were observed almost ex-
clusively in AMs and rarely in neutrophils. The distribu-
tion of particles within the lavagable AMs was heteroge-
neous, and changed slightly as a function of time PI
(Figure 4). The vast majority of AMs at all time intervals
contained no particles and, of the cells that had phagocy-
tized particles, most contained only 1 or 2 particles, but as
many as 72 particles were observed within a single AM.
The proportions of AMs in all categories increased expo-
nentially from zero as particles were phagocytized during
the first 24 h PI, and continued to increase slightly be-
tween 1 and 4 d, with the exception that the “one particle
per cell” category declined slightly between 1 and 4 d PI.
This initial growth phase was followed by decline, which is
evident between 4 and 91 d PI, most prominently in the
higher burden categories. The proportion of AMs in the
“one particle per cell” category, however, increased slowly
between 4 and 91 d (doubling time, 155 days). In the lower
burden categories (up to seven particles), the majority of
the cell loss occurred between 28 and 91 d PI, whereas in
larger particle burden categories (eight or more particles),
loss of cells began earlier, between 4 and 28 d, and contin-
ued through 91 d PI. The percentage of cells in each of the
three largest burden categories was significantly lower at
91 d than at 4 d PI (ANOVA and Tukey’s HSD post hoc
comparisons, P , 0.05). The coefficients, decay constants,
Figure 3. (Top) The total number of particle-laden AMs recov-
ered by BAL (combined alveolar 1 bronchial fractions) de-
creased slightly between 1 and 91 d PI (no statistically significant
change). Bars represent standard error. (Bottom) The percentage
of particle-laden AMs appeared to increase slightly between 2
and 91 d PI in both alveolar and bronchial BAL fractions. The
percentages of particle-laden AMs were lowest at 1 d PI, owing to
the transient influx of AMs. *Alveolar fraction statistically differ-
ent from bronchial fraction (P 5 0.035, paired t test). Bars repre-
sent standard error.
Figure 4. The distributions of particle-laden AMs in the various
particle burden categories are similar in bronchial and alveolar
fractions, especially for smaller particle burden categories. In the
alveolar fraction, the percentage of cells in the larger categories
clearly decreased more rapidly than in smaller burden categories.
(Error bars were intentionally omitted to avoid excessive clutter.)
*Significantly different from 4 d PI (ANOVA, P , 0.05). †Signifi-
cantly different from corresponding value in alveolar fraction.
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and half-times for long-term exponential functions fit to
the various categories are listed in Table 1 for both alveo-
lar and bronchial fractions. It is clear from these fitted pa-
rameters that there was a progressive increase in the rate
of disappearance of particle-laden AMs as their particle
burdens increased. On the basis of the calculated half-
times, AMs in the 201 particle category cleared approxi-
mately 40 times faster than AMs in the 2- to 4-particle cat-
egory.
Bronchial fraction. As in the alveolar fraction, parti-
cles were observed almost exclusively in AMs and occa-
sionally in neutrophils. Compared with the alveolar frac-
tion, there were many degenerate cells in the bronchial
lavagate, many of which were probably epithelial cells.
Degenerated or lysed cells with associated particles were
presumed to be AMs; however, it is possible that some
were epithelial cells. We did not see particles associated
with cells definitively identified as epithelial cells. The pro-
portional distributions of AMs in the four lowest particle
burden categories (1 through 8–11 particles) at the various
times PI were similar to those of the alveolar fraction (Fig-
ure 4). In contrast to the alveolar fraction, the percentages
of phagocytic AMs in the two highest particle burden cate-
gories (12 to 19, and 20 or more particles) in the bronchial
fraction remained relatively constant between 1 and 28 d
PI and diminished slightly between 28 and 91 d PI (not sta-
tistically significant, ANOVA). The percentage of phago-
cytic AMs in the 20-or-more particle category was signifi-
cantly lower in the bronchial fraction compared with the
alveolar fraction at 4 d PI (0.35 6 0.26 versus 1.74 6 0.48,
paired t test, P 5 0.04); however, there was no significant
difference between bronchial and alveolar fractions at 91 d
PI for either of these two highest particle burden categories.
Differences in disappearance of AMs from correspond-
ing particle burden categories of bronchial and alveolar
fractions are most apparent as differences in clearance
rate constant (l) and t1/2 as listed in Table 1. Pearson’s cor-
relation coefficients for particle burden category versus l
were significantly greater than zero for both alveolar and
bronchial fractions (P 5 0.003 and P 5 0.019, respec-
tively), indicating trends toward increasing rates of clear-
ance (AM disappearance) as a function of increasing parti-
cle burden. Regression lines demonstrating trends in rates
for the two BAL fractions are plotted in Figure 5. The
slopes of the two trend lines are slightly (but not statisti-
cally) different; however, the lines are different as defined
by differences in their respective y intercepts (ANCOVA,
P 5 0.006).
Cell Counts in BAL Fluid 
The instillation of Fe2O3 particles into the lingular subseg-
ment resulted in a transient inflammatory response that
was apparent in some of the subjects at 1 d PI. This cellular
response was characterized by the influx of both AMs and
neutrophils (Table 2). Although there were large differ-
ences in the mean number of cells recovered from control
and particle-instilled segments, large variances in cell
numbers in the lingular lavagate prevented the differences
from being statistically significant. The number of AMs in
BAL fluids from the particle-instilled segment returned to
control levels by 2 d PI. The mean total number and per-
centage of neutrophils in the lingular alveolar BAL fluid
TABLE 1
Fitted parameters for exponential decay function*
Category
(particle per cell)













1 54.24 0.00036† 0.99 1,944‡ 43.02 0.0047† 0.96 155‡
2 to 4 29.94 0.00098 0.98 707.9 36.48 0.0023 0.88 345.2
5 to 7 9.01 0.0017 0.88 414.0 9.84 0.0056 0.86 123.2
8 to 11 5.20 0.0095 0.98 73.0 6.20 0.017 0.99 40.3
12 to 19 2.64 0.013 0.92 53.4 4.15 0.054 0.98 12.8
20 or more 0.72 0.021 0.75 32.7 2.42 0.082 0.99 8.4
* These parameters represent the coefficients (A) and rate constants (l) of long-term retention functions corresponding to Equations 3 or 4.
† Positive exponential.
‡ Value for 1 particle per cell category is doubling time, not half-time.
Figure 5. The rate constants governing the disappearance of
AMs from the various particle burden categories tended to in-
crease with increasing intracellular particle burden for both alve-
olar and bronchial fractions. Pearson’s correlation coefficients (r)
for alveolar (0.981, P 5 0.003) and bronchial fractions (0.936, P 5
0.019) are significant and positive. The slopes of the regression
lines are similar, but y intercepts are significantly different (P 5
0.006).
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was still marginally elevated at 2 d PI (although not statis-
tically significant), and were no different from control val-
ues at 4 d PI and later. 
Discussion
The relationship between lavagable particle burden and
total particle burden has been clearly demonstrated by
Lehnert and colleagues (8), who showed in rats that the
lavagable burden was a proportional reflection of the to-
tal lung burden. Studies in sheep (7) and rats (2, 8, 28)
showed that the bulk of the pulmonary particle burden is
associated with AMs and that the AM population sampled
by BAL is representative of the overall AM population
with respect to the intracellular particle distribution. Real-
izing that we did not recover all the particles in the lung, or
even all the particles in the lavagable spaces, we contend
that in our study BAL resulted in recovery of a quantity of
particles that is proportional to the total lung burden and
that could be used to study changes in intracellular particle
distribution and estimate retention and clearance kinetics
for particles in the lavagable AM compartment.
Our comparisons of intracellular particle distributions
at the various time points clearly demonstrate dispropor-
tionate rates of cell loss from the various categories in
both alveolar and bronchial fractions. The rate of cell dis-
appearance is dramatically greater in the high particle bur-
den categories, similar to the findings in previous studies
(8). The continued growth of the “one particle per cell”
category in the face of decline in other categories might be
explained by one of several mechanisms. The first is that
cells in the higher categories may be preferentially cleared
physically from the lung at a more rapid rate than cells in
the smaller particle burden categories, thus the relative
proportions of AMs in the smaller burden may actually
continue to grow. This would require greater mobility and
disproportionately more rapid movement onto the muco-
ciliary apparatus or into the interstitium by AMs with high
particle burdens. Evidence provided by other investiga-
tors, however, indicates that AMs heavily laden with parti-
cles actually tend toward decreased mobility (28, 29). A
second explanation might be a change in the lavagability
of AMs in the various particle burden categories with the
passing of time. This seems unlikely because findings simi-
lar to ours were made by Lehnert and associates (8), who
examined not only lavaged AMs, but also AMs remaining
in the lung after lavage. 
A third, and perhaps most probable, explanation might
be that particles released by cells in the higher burden cat-
egories are rephagocytized by other cells, resulting in “re-
distribution” of particles from one cell to another. The
possible mechanisms underlying cell-to-cell particle redis-
tribution have previously been discussed in detail else-
where (30). The cells that phagocytize the released parti-
cles are most likely to be cells that previously did not
contain particles, because, proportionally, they are much
more abundant than particle-laden AMs. This redistribu-
tion might occur following exocytosis of particles by viable
cells, lysis of dead or degenerate cells, or phagocytosis of
whole dead or degenerating cells. Our data seem consis-
tent with the possible occurrence of a particle redistribu-
tion phenomenon in our human subjects. The true expla-
nation for our observations may be a combination of
mechanisms rather than just one single mechanism.
The proportions of AMs in the various particle burden
categories were similar in alveolar and bronchial fractions,
although there were apparent differences in the rates of
AM disappearance from corresponding categories in the
two BAL fractions. We interpret this to indicate that many
of the AMs in the bronchial fraction are most likely
egressing AMs that have moved from the alveolar region
into the airways, resulting in an apparent lag in clearance
from the bronchial region. This also suggests that mobility
of AMs toward the bronchial airways may not be influ-
enced by their particle burdens.
The fast clearance phase (t1/2 5 0.5 d) found in our
study is much faster than that (t1/2 5 12–19 d) found by
others in rats (8, 31) and is representative of the early
clearance (0 to 4 d), which probably includes mucociliary
clearance of particles from small peripheral airways in ad-
dition to rapid-phase alveolar clearance. Our data do not
allow for the resolution of a distinct intermediate phase of
relatively rapid alveolar clearance comparable to that de-
scribed in the rats (8). It is incorporated into the long-term
clearance phase and undoubtedly influences our calcu-
lated value for the long-term clearance half-time. Addi-
tional subjects and groups examined between 4 and 28 d
PI and beyond 91 d PI would probably allow for more con-
fidence in resolving fast and slow components. Given the
marked disparity in long-term clearance rates between hu-
mans and rats (10), we would have expected to see a much
slower long-term clearance half-time in our human sub-
jects as compared with rats (8).
The long-term clearance half-time of 110 d found in our
BAL study is within the range of half-time values (62 to
300 d) found by others using radioactive tracer or mag-
netic methods to measure clearance of iron oxide particles
(32–34), polystyrene (12, 13), or Teflon particles (20). This
is much faster, however, than the mean 272-d half-time
found by Bailey and coworkers (11) for clearance of radio-
labeled 3.9-mm fused aluminosilicate particles in humans,
in which it was found that the calculated half-time in-
creased with increasing length of the study. Thus, the cal-
culated half-time in our study may have been affected by
the relatively short length of the study period.
TABLE 2
Total cells, alveolar macrophages, and neutrophils in








Total cells‡ 20.0 6 7.72 2.95 6 0.40 0.08
Alveolar macrophages§ 9.68 6 2.62 2.70 6 0.39 0.05
Neutrophils§ 9.35 6 4.9 0.046 6 0.015 0.11
* Twenty-four hours postinstillation. All values are mean 6 standard error.
† Student’s t test for paired measurements, P value < 0.05 indicates statistical
significance. Large variances in cell counts in the particle-instilled segment pre-
vented the differences from being statistically significant.
‡ Combined bronchial and alveolar fractions.
§ Alveolar fraction.
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Our technique only samples the retention of the lavaga-
ble cells and particles; whereas the external monitoring of
inhaled radiolabeled particles assesses retention of all par-
ticles, including those sequestered within epithelial cells,
the interstitium, and thoracic lymph nodes. Thus, our
method tends to underestimate retention and overesti-
mate clearance of particles when there is significant move-
ment of particles into the interstitium. It is likely that the
large number of particles and the transient inflammation
in our study may have resulted in greater than usual access
of particles to the interstitium, where they would be inac-
cessible to lavage. Studies in mice (35) and rats (36), how-
ever, indicate that instilled inert particles of at least 1-mm
diameter are unlikely to penetrate to the interstitium.
Even so, because the majority of inhaled particles become
associated with AMs (2, 7) and because the lavagable par-
ticle burden is proportional to the total burden (8), it is
likely that sampling by BAL reflects the kinetics of reten-
tion and clearance of particles in the AM compartment
and within the alveolar spaces. 
A transient cellular influx, similar to that in the current
study, has been observed following instillation of polysty-
rene (37) or carbon particles (38) and following inhalation
of ferric oxide dust (39). This inflammation may result
from release of neutrophil chemoattractants by AMs (40),
complement activation (41), or the presence of small
amounts of soluble ferric ion (Fe31) (42) that may have
been associated with the particles used in our study. The
sudden introduction of large numbers of particles and sub-
sequent phagocytic activity by AMs also may result in ac-
cidental release of lysosomal contents (hydrolases, pro-
teases, reactive oxygen species, and other products) during
phagocytosis (premature fusion of lysosome with phago-
some), leading to inflammation.
Studies have examined and quantified particles within
lavaged AMs in attempts to index pulmonary particle bur-
dens in occupationally exposed individuals (43). Because
occupational dust exposures generally involve nonradioac-
tive materials, estimation of pulmonary particle burden
and clearance kinetics is difficult. The current study dem-
onstrates that sampling of the lavagable particle burden by
BAL over a period of time can yield an estimate of parti-
cle retention kinetics comparable to that obtained by
other, more traditional methods, such as external monitor-
ing of radiolabeled particles. BAL, thus, may be useful not
only for assessing pulmonary particle burdens, but also for
predicting particle retention kinetics following occupa-
tional inhalation exposure to insoluble dusts.
This is the first study to employ intrapulmonary instilla-
tion of particles and BAL to study kinetics of pulmonary
particle retention and clearance in human subjects. It dem-
onstrates the usefulness of BAL for studying intrapulmo-
nary particle burdens by sampling lavagable AMs, which
are crucial for clearance of particles from the alveolar re-
gion and that also serve as a compartment for storage or
sequestration of a large proportion of the total lung bur-
den of insoluble particles. With this technique we demon-
strated disproportionate “clearance” (disappearance) of
AMs with high particle burdens, suggestive of a particle
redistribution phenomenon similar to that described in
rats. In addition, we were able to estimate a long-term
clearance half-time comparable to that determined by
more traditional methods. Finally, we demonstrated a
transient acute inflammatory response to the particles at
1 d PI, a finding that may be important in the light of stud-
ies showing acute adverse health effects of ambient partic-
ulate air pollution. 
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